Document is current

Article History

Received: 20 May 2024

Accepted: 8 September 2024

First Online: 14 October 2024

Declarations

:

: All patients provided informed consent prior to data collection. Ethical approval was provided by the Western Institutional Review Board (protocol number: 20203287). Data collection was undertaken in line with European Pharmaceutical Marketing Research Association guidelines []. Each survey was performed in full accordance with relevant legislation at the time of data collection, including the US Health Insurance Portability and Accountability Act 1996 [], Health Information Technology for Economic and Clinical Health Act legislation [], and the Declaration of Helsinki []. No personally identifiable data were collected. Physician and patient data were pseudonymized by assigning a code to each response, which allowed for matching of patient self-complete and patient record forms.

: Not applicable as we are not publishing any personally identifiable data.

: NC, RA and SB are employees of Adelphi Values. Adelphi Values conducted the study analyses. Adelphi Values were paid consultants to Adelphi Real World in connection with the development of this manuscript. AT was an employee of Adelphi Values at the time of study. JS is paid as a consultant to Adelphi Values. VH, JP are employees of Adelphi Real World who funded the development and validation of the Adelphi Adherence Questionnaire.